There were 534 press releases posted in the last 24 hours and 394,063 in the last 365 days.
ILLINOIS, March 17 - Public Health Officials Launched Distribution this Week of HEPA Air Purifiers to Schools Across Illinois to Help Reduce Transmission of Respiratory Viruses
IDPH has recorded a total of 4,092,258 cases and 36,494 deaths, in 102 counties in Illinois since the beginning of the pandemic. The department is reporting 8,966 new confirmed and probable cases of COVID-19 in Illinois in the week ending March 12, and 63 deaths.
This week, IDPH also announced that it is working with the Illinois State Board of Education (ISBE) to distribute HEPA (High Efficiency Particulate Air) air purifiers to almost 3,000 schools throughout the state to protect students and schools' staff by reducing the transmission of respiratory viruses, including COVID-19. The $30 million program is funded through the CDC.
"I am very pleased to be working with our partners at ISBE to help improve air quality in Illinois' classrooms," said IDPH Director Dr. Sameer Vohra. "Data over these last three years have shown us the critical importance of good ventilation to keep children and adults safe from respiratory illnesses. These HEPA air purifiers are a significant investment in our children. They will keep kids healthy and in school, ensuring more opportunities for learning and success."
IDPH is helping Illinoisans stay prepared for any future surge of COVID-19 cases by offering 1 million free COVID-19 rapid antigen tests to Illinois residents in all zip codes outside the City of Chicago through a partnership with the Rockefeller Foundation's public charity, RF Catalytic Capital and its Project ACT (Access COVID Tests) program.
The CDC authorized two new bivalent booster vaccines on September 1 that include an mRNA component of the original strain to provide an immune response that is broadly protective against COVID-19 and an added mRNA component in common between the omicron variant BA.4 and BA.5 lineages to provide better protection against COVID-19 caused by the omicron variant.
Initially, the Moderna COVID-19 Vaccine, Bivalent, was authorized for use as a single booster dose in individuals 18 years of age and older and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, was authorized for use as a single booster dose in individuals 12 years of age and older. On October 12, the CDC authorized the updated COVID-19 vaccines from Pfizer-BioNTech for children ages 5 through 11 years, and from Moderna for children and adolescents ages 6 through 17 years.
On December 9, the CDC expanded its authorization for bivalent boosters to include children aged 6 months to 5 years. Children ages 6 months through 5 years who previously completed a Moderna primary series can now receive a Moderna bivalent booster 2 months after their final primary series dose. Children ages 6 months through 4 years who are completing a Pfizer primary series will receive a Pfizer bivalent vaccine as their third primary dose.
As of last night, 824 individuals in Illinois were reported to be in the hospital with COVID-19. Of those, 107 patients were in the ICU and 36 patients with COVID-19 were on ventilators. The preliminary seven-day statewide case rate is 70 COVID-19 cases per 100,000 Illinoisans.
In counties at the Medium Community Level, persons who are elderly or immunocompromised (at risk of severe outcomes) are advised to wear a mask in indoor public places. They should also get up to date on COVID-19 vaccines or get their bivalent booster, if eligible.